Each individual picks a cosmetic procedure for some individualized dreams. Opting for a facelift stems from the desire to look youthful and refreshed. The procedure is highly impactful in terms of delivering patients’ desired outcomes. However, there are certain complications associated with it.
Table of Contents
One such complication, which, although not very common, can pose significant challenges to the patient, is skin necrosis. Necrosis of the skin can result from a lack of proper blood supply to the area, resulting in tissue death. Understanding the condition, as well as the methods involved in avoiding it and treating it, is vital for a safe and satisfactory procedure.
Pathophysiology of Skin Necrosis
Facial skin receives blood from a network of tiny vessels. These perforating vessels carry blood through muscles and subcutaneous tissue beneath the skin. During a facelift surgery, the skin and tissues are elevated as a surgical flap. The act of lifting this flap naturally disrupts some of these perforating connections.
As a result, the elevated flaps become dependent on the rest of the intact vessels for the maintenance of proper oxygenation. Hence, the remaining vessels must work harder to keep the skin alive and supply oxygenated blood. If oxygen delivery drops below a critical level, the skin becomes ischemic. Moreover, if blood flow is not restored quickly, then starvation occurs first in the deeper layer, and then follows the outer layers of the skin.
Due to this oxygen deficiency, skin cells begin to die. The most vulnerable areas are the farthest edges of the flaps, known as the distal margins. Consequently, the terminal zone, near the temples and behind the ears, is at greater risk during facelift surgery treatment.
Major Causes and Risk Factors
There are several factors that increase the risk of skin necrosis. These patient-related variables increase the likelihood of complications following facelift surgery.
- Smoking is a well-documented risk factor among them. Nicotine causes severe vasoconstriction. In turn, it reduces the oxygen-carrying capacity of the hemoglobin by narrowing the blood vessels. As a result, smokers have a higher probability of ischemic transition into tissue death.
- Another factor is diabetes mellitus. It’s an important contributor because of its microvascular disease-causing nature. It impairs the integrity of small blood vessels. This limits the skin’s capacity to receive enough oxygenated blood during the recovery phase.
- Similarly, hypertension and connective tissue disorders also compromise overall vascular health, thereby elevating the surgical risks. Moreover, it’s necessary to check the prior facial radiotherapy status. If someone has prior radiation therapy, then it permanently alters the face tissues’ perfusion. It will make the skin susceptible to poor healing.
- Age-related changes in skin elasticity and vascularity also contribute to these risks. Less elastic skin due to aging may present more drastic consequences.
- Previous surgery: Patients with a history of previous facelift procedures have existing scar tissue. This scar tissue further restricts the collateral blood supply to that key region of the face. In turn, facelift surgery becomes challenging from a vascular standpoint.
Surgical Factors Affecting Perfusion
There are some factors that badly affect tissue perfusion. The intraoperative decisions and the thickness of the dissected flap are among them. These are the most critical variables a surgeon controls, as they have a direct and immediate impact on tissue perfusion. When the flap is raised too thin, severe damage can occur.
More likely, the dermal plexus, which forms the primary vascular network of the skin, can be damaged during dissection. As a result, the skin loses its natural vascular support. Then it becomes entirely dependent on perfusions from the base of flaps.
Severe tension at the closure line is another technical risk factor. When the skin is sutured too tightly, the mechanical compression hinders blood flow at the incision margins. This compression comes from the superficial blood capillary. In turn, the postauricular and temporal hairline areas experience the greatest tension. It becomes the most frequently affected site.
Similarly, excessive use of cauterization during hemostasis can damage adjacent blood vessels, further compromising local perfusion. The goal is not to avoid hemostasis entirely but to use it judiciously to preserve as many surrounding vessels as possible.
Post Operative Elements
Certain postoperative developments also contribute to skin necrosis in facial procedures such as facelift and rhinoplasty surgery. Hematoma formation is the most common early complication following facelift surgery. It begins with a small collection of blood pooling beneath the skin flap, which exerts pressure on the overlying tissues.
In turn, this pressure disrupts capillary blood flow, leading to compromised perfusion. As a result, ischemia develops in the affected tissues. If a hematoma is not identified and promptly drained, it may progress to full-thickness necrosis.
Surgical site infection presents a secondary risk in both facelift and rhinoplasty surgery. Bacterial colonization triggers an inflammatory response, damaging local blood vessels and increasing the metabolic demands of tissues that may already have reduced blood supply. Therefore, meticulous postoperative wound care is essential, as early detection and management of infection play a critical role in ensuring proper healing and recovery.
Clinical Presentation
The clinical signs of skin necrosis in facelift appear within the first few days to weeks after the facelift surgery. These signs are visible with discoloration of the skin area showing necrosis. This change occurs due to cellular death advancement through the dermal layers.
| Time after surgery | What to look for |
| Day 1-2 | Pale or dusky grayish skin |
| Day 2-4 | Blue-gray or dark brown discoloration |
| Day 4-7 | Blistering, wounded edges are separating |
| Later | Black, dry tissue, foul smell, infection |
Preventive Strategies
Prevention of skin necrosis in facelift begins with careful patient selection. It also needs preoperative optimization with structured protocols for high-risk individuals.
| Phase | Action |
| Before surgery | Stop nicotine for 4 to 6 weeks Control blood sugar Need medical clearance |
| During surgery | Good flap thickness required Minimal tension Preserve vesselLimit cautery (use of extreme heat or cold) to cut or seal body tissue. |
| After surgery | Monitor hematomaAvoid tight dressings Head elevation |
| If necrosis occurs | Moist dressingsDebridementskin graft if it is largescar revision at 6-12 months |
Conclusion
In summary, complete avoidance of all complications during any surgical procedure is impossible. So is true for cosmetic surgeries. Skin necrosis in facelift surgery is a common complication but easily manageable. It needs early recognition with the structural clinical methodology to get fine results.
Therefore, a combination of preoperative screening under the observation of an accomplished surgeon is necessary. It will help patients avoid serious complications and risk factors. Moreover, being vigilant about your skin presentation could help to identify and treat the issue at its earliest. Thus, precise and attentive postoperative forms will make a most reliable foundation for a safe and successful facelift surgery experience.
As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before changing your wellness routine. WHN neither agrees nor disagrees with any of the materials posted. This article is not intended to provide a medical diagnosis, recommendation, treatment, or endorsement.
Opinion Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy of WHN. Any content provided by guest authors is of their own opinion and is not intended to malign any religion, ethnic group, club, organization, company, individual, or anyone or anything else. The Food and Drug Administration has not evaluated these statements.
